Background
==========

Leber hereditary optic neuropathy (LHON, MIM535000) is one of the most common mitochondrial disorders, which mainly leads to vision loss in young males \[[@B1]-[@B3]\]. Three primary mutations (m.3460G \> A in the *MT-ND1*gene, m.11778G \> A in the *MT-ND4*gene, and m.14484T \> C in the *MT-ND6*gene) accounted for the etiology of more than 95% LHON patients, whereas the remaining 5% cases was caused by rare mutations and/or unclear factors \[[@B1]-[@B3]\]. Up to now, there is a considerable long list for rare mutations for LHON (cf. <http://www.mitomap.org>). Most recently, m.3635G \> A in the *MT-ND1*gene was confirmed to be a rare primary mutation and had a multiple occurrence in Han Chinese and Russian LHON families \[[@B4]-[@B7]\]. Clinical expression of primary LHON mutation was affected by many factors including mtDNA background/haplogroups \[[@B8],[@B9]\], nuclear genes \[[@B10]-[@B12]\] and environmental factors \[[@B2],[@B13]\]. Though more and more LHON risk factors have been identified, there are abundant suspected LHON patients without any reported pathogenic mtDNA mutations \[[@B14],[@B15]\].

In our recent study, we found mutation m.10680G \> A in a suspected LHON family lacking any known primary mutation, and this family had a considerably high penetrance of disease (40%; \[[@B15]\]) compared with that of families with m.11778G \> A (about 33.3%; \[[@B8]\]). Similarly, Yang *et al.*\[[@B16]\] reported one Chinese LHON family with both m.10680G \> A and primary mutation m.14484T \> C which expressed complete penetrance. These two studies suggested that m.10680G \> A played an active role in LHON and might be a \"suspected\" pathogenic LHON mutation. In order to investigate the frequency of m.10680G \> A in Chinese patients with clinical LHON features but without any known mutations, we screened this mutation in 774 suspected LHON patients by using the allele specific PCR (AS-PCR). Our analysis of the complete mtDNA genomes of the probands with mutation m.10680G \> A suggested that this mutation should be regarded as a rare pathogenic mutation for LHON in Chinese.

Materials and methods
=====================

Patients
--------

The patients were physically evaluated and collected at the Pediatric and Genetic Clinic of the Eye Hospital, Zhongshan Ophthalmic Center and/or other local clinical centers. All patients were subjected to acute or sub-acute vision loss and lacked the three known LHON primary mutations. We have sequenced the mtDNA control region sequence and classified these patients with suspected LHON into respective haplogroup and found no haplogroup was associated with suspected LHON \[[@B17]\]. Because we used up DNA samples for some patients during that study, only 774 out of 843 patients with suspected LHON \[[@B17]\] were analyzed here. All these 774 patients were confirmed to harbor none of the four LHON primary mutations (m.3460G \> A, m.3635G \> A, m.11778G \> A, and m.14484T \> C). Informed consents conforming to the tenets of the Declaration of Helsinki were obtained from each participant prior to the study. The institutional review boards of Zhongshan Ophthalmic Center and Kunming Institute of Zoology approved this study.

Detection of mutation m.10680G \> A
-----------------------------------

Mutation m.10680G \> A was genotyped by using the AS-PCR in 774 suspected LHON patients. The primer pair for AS-PCR (L10680A: 5\'-AGTCTTTGCCGCCTGCGATA-3\'/H10972: 5\'-TCAGGTAGTTAGTATTAGGAG-3\') was designed according to the strategy described in Bi *et al.*\[[@B18]\]. Another primer pair L4887 (5\'-TGACAAAAACTAGCCCCCATCT -3\')/H5442 (5\'-GCGATGAGTGTGGGGAGGAA-3\') was used as the internal control for monitoring successful amplification during the AS-PCR. PCR was performed in a total volume of 20 μL containing 30 ng DNA, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl~2~, 50 mM KCl, 0.5 units of TaKaRa rTaq, 175 μM of each dNTP, and 0.3 μM of each primer. The amplification condition for AS-PCR is composed of one denaturation cycle at 94°C for 3 min, 30 cycles of denaturation at 94°C for 20 s, annealing at 61°C for 20 s, and extension at 72°C for 30 s, and one final extension cycle at 72°C for 5 min. In order to evaluate the sensitivity of the AS-PCR in detecting the minimum level of heteroplasmic mutation m.10680G \> A, five different concentrations of genomic DNA of patient Le1263 with m.10680G \> A (1 ng, 2.5 ng, 5 ng, 10 ng, and 15 ng) was used for amplification. In addition, DNA samples from patient Le1263 and a healthy donor without m.10680G \> A were mixed to achieve final proportions of mutant DNA of 5%, 10%, and 20%, and a total of 30 ng of mixed DNA was amplified. The sensitivity is defined to be the smallest percentage of mutant DNA that can be detected by the AS-PCR method. PCR products were separated on 1.5% agarose gel at 120 V for 30 min.

Analysis of the entire mtDNA genome for patients with m.10680G \> A
-------------------------------------------------------------------

The entire mitochondrial genomes of probands with m.10680G \> A were amplified and sequenced by using primers and methods described in our previous study \[[@B19]\]. Sequences were handled by the DNASTAR program (DNAS Inc, Madison, WI, USA). We classified each patient into accurate haplogroup relative to the updated East Asian mtDNA tree and PhyloTree \[[@B20]-[@B22]\]. The novelty of variants/mutations was defined according to the available guidelines described by Bandelt *et al.*\[[@B23]\]. We presented mtDNA sequence variations in probands sequenced in this study, together with two reported LHON mtDNAs with m.10680G \> A (family Le1107 reported by Zou *et al.*\[[@B15]\] and LHON family reported by Yang *et al.*\[[@B16]\]) in a mtDNA tree. This phylogenetic approach has been demonstrated to be powerful to recognize private variants and haplogroup-specific variants in each lineage \[[@B23]\]. Evolutionary conservation analysis of m.10680G \> A was performed by using the MitoTool (<http://www.mitotool.org>) \[[@B24]\].

To discern the frequency of m.10680G \> A in reported mtDNAs across world, we collected 9277 complete (and/or incomplete) mtDNA sequences from PhyloTree (mtDNA Tree Build 12, 20 Jul 2011) \[[@B21]\] and the MitoTool data set \[[@B24]\] and excluded those data of Chinese LHON patients. The ten reported Chinese patients with suspected LHON in our recent study \[[@B15]\] were aggregated with the patients screened in this study. Two tailed Fisher Exact test was used to evaluate the difference of m.10680G \> A frequency between Chinese patients with suspected LHON and the reported data. A *P*value less than 0.05 was considered as significant.

Results
=======

Optimization of the AS-PCR for detecting m.10680G \> A
------------------------------------------------------

As demonstrated in Figure [1A](#F1){ref-type="fig"}, two bands could be amplified by using the allele-specific primer pair L10680A/H10972 (product length is 312 bp) and the internal control primer pair L4887/H5442 (product length is 596 bp) in the presence of mutation m.10680G \> A. This AS-PCR approach had a relatively high sensitivity: 1) the specific band for m.10680G \> A could be well recognized when 10 ng DNA was used, despite the fact that DNA template of 5 ng could also yield a weak target band; 2) we could detect m.10680G \> A when it had a proportion of mutant DNA of 10% of total DNA template (Figure [1B](#F1){ref-type="fig"}).

![**Optimization of the allele-specific PCR method for detecting m.10680G \> A**. The DNA template of proband Le1263 was diluted to have different concentrations with 1 ng, 2.5 ng, 5 ng, 10 ng, and 15 ng, respectively, to determine the smallest concentration of genomic DNA that could be detectable by the AS-PCR method. Normal controls were confirmed to lack mutation m.10680G \> A. Patients Le1263, Le1330 (this study) and Le1107 in our previous study \[[@B15]\] harbored mutation m.10680G \> A (A). Genomic DNA templates of patient Le1263 and normal control \#1 were mixed to reach different proportions of mutant DNA. The percentage of mutated DNA stepwise from 5% to 20% (the mid-concentration is 10%), to determine the smallest percentage of mutant DNA (B). PCR products were separated on 1.5% agarose gel. The upper band (596 bp) is the internal control and the lower band (312 bp) indicates the presence of mutation m.10680G \> A.](1479-5876-10-43-1){#F1}

Clinical data and frequency of m.10680G \> A in patients with suspected LHON
----------------------------------------------------------------------------

We identified two patients (Le1263 and Le1330) with homoplasmic mutation m.10680G \> A in 774 patients analyzed by the AS-PCR. Patient Le1263 is a 47 year-old man from Guangdong Province and has no self-reported family history of disease. He had felt an acute vision loss in both eyes for 33 days when he came to hospital. His best visual acuity is 0.2 for the right eye and 0.1 for the left eye at the time of his visit to our clinic. Fundus observation revealed mild pale of the optic disc in the right eye and mild edema of the optic disc with enlarged retinal vessels in the left eye. He had normal cornea, lens, and intraocular pressure (8 mmHg for the right eye and 11 mmHg for the left eye). Patient Le1330 is a 19 year-old man from Sichuan Province and has a family history of disease (Figure [2](#F2){ref-type="fig"}). He had acute vision loss for both eyes about 5 years ago. Ocular examination revealed pale temporal disc. Five other maternal relatives in his family had acute bilateral vision loss at around 30 years old (Figure [2](#F2){ref-type="fig"}), which is consistent with a pattern of maternal inheritance.

![**Pedigree of LHON family Le1330 with m.10680G \> A**. Filled symbols represent affected individuals with LHON. The proband that was analyzed for the complete mtDNA sequence was marked by an arrow.](1479-5876-10-43-2){#F2}

The overall frequency of m.10680G \> A in Chinese patients with suspected LHON was considerably low (0.26% = 2/774), although this frequency was significantly higher than that of the complied mtDNA data set for world populations (0/9277) (*P*= 0.006). When we included ten suspected LHON patients with family history that were reported in our previous study \[[@B15]\], the total frequency increased to 0.38% (3/784) (compared to the complied mtDNA data, *P*= 0.0005). A web-based search and database search \[[@B23]\] showed that mutation m.10680G \> A only occurred in Chinese LHON patients. The penetrance of LHON in family Le1330 was relatively high (6/14 = 42.9%), similar to the reported family Le1107 (8/20 = 40.0%) in our previous study \[[@B15]\]. All these results suggest that the rare mtDNA mutation m.10680G \> A participates in the pathogenesis of LHON in Chinese.

Multiple occurrence of m.10680G \> A in different Chinese mtDNA lineages
------------------------------------------------------------------------

Analysis for the complete mtDNA genomes of the two patients with m.10680G \> A suggested that Le1263 and Le1330 belonged to haplogroups B4a1 and D6a1, respectively (Sequence could be retrieved from GenBank via accession numbers [JN866824](JN866824) and [JN866825](JN866825)). Excluding these haplogroup-specific variants and mutation m.10680G \> A, we found 11 private variants in Le1263 and 8 private variants in Le1330. Most of these private variants were synonymous or were located in the non-coding region. No \"confirmed\" or \"suspected\" LHON-associated mutation (which was listed in MITOMAP database: <http://www.mitomap.org/bin/view.pl/MITOMAP/MutationsLHON>) was found in these two patients (Figure [3](#F3){ref-type="fig"} and Table [1](#T1){ref-type="table"}). One non-synonymous variant in the *MT-ND1*gene (m.3548T \> C, p.I81T) and one variant in the *MT-RNR2*gene (m.2352T \> C) were found in patient Le1263, whereas patient Le1330 had two missense variants in the *MT-ND1*gene (m.3745G \> A, p.A147T) and the *MT-ND5*gene (m.13327A \> G, p.T331A). Except for variant m.2352T \> C, the other three non-synonymous variants had a considerably high conservation index (CI) (\> 0.8) (Table [1](#T1){ref-type="table"}), suggesting these positions being evolutionarily conserved. All these private variants have been reported in the general populations, and variant m.3548T \> C has been previously reported in patients with LHON \[[@B25]\] and diabetes \[[@B26]\].

![**Classification tree of four mtDNAs with m.10680G \> A**. Two reported LHON mtDNAs (Le1107 \[[@B15]\] and FJ986465 \[[@B16]\]) were adopted from published sources. The revised Cambridge reference sequence (rCRS) \[[@B27]\] was included to show the phylogenetic relationship of the lineages and haplogroup-specific variants. The order of variants on each uninterrupted branch section is arbitrary. Haplogroup names were placed on each branch to show their hierarchical and nested positions within macrohaplogroups M and N. Recurrent variants were underlined. Deletion of nucleotide(s) was indicated by suffix \"d\". Length mutations of the C-tract in region 303-309 were omitted from the tree. Mutation m.10680G \> A was marked in boldfaced. The synonymous and non-synonymous coding-region variants in these mtDNAs were further denoted by \"/s\" and \"/ns\", respectively. Variations in the ribosomal RNA genes and tRNA genes were denoted by \"/r\" and \"/t\", respectively.](1479-5876-10-43-3){#F3}

###### 

Private mtDNA variants in two Chinese probands with m.10680G\>A

  Sample   Nucleotide variant (Amino acid change)   Gene         **CI**^**a**^   **Population report**^**b**^   **Disease report**^**b**^
  -------- ---------------------------------------- ------------ --------------- ------------------------------ ---------------------------
  Le1263   m.3548T \> C (p.I81T)                    *MT-ND1*     0.907           Yes                            Yes
           m.2352T \> C                             *MT- RNR2*   0.047           Yes                            No
  Le1330   m.13327A \> G (p.T331A)                  *MT-ND5*     0.837           Yes                            No
           m.3745G \> A (p.A147T)                   *MT-ND1*     0.884           Yes                            No

^a^Conservation index (CI) was estimated by using 43 primate species according to the MitoTool \[[@B24]\].

^b^The search was performed on Oct 31, 2011 following the same strategy described earlier \[[@B23]\] (e.g. both \'T3548C mtDNA\' and \'m.3548T \> C mtDNA\' were queried).

Discussion
==========

Though over 95% LHON patients was affected by one of the three primary mutations, the etiological factor of the remaining 5% LHON patients was unclear \[[@B1]-[@B3]\]. Many sporadic cases without three primary mutations have been reported and mtDNA mutations identified in these lineages were considered as pathogenic, despite the fact that the exact pathogenicity remains to be proved by functional assays. The spectra of the LHON primary mutations showed remarkable difference between European patients and Chinese patients \[[@B8],[@B9],[@B28]-[@B30]\], we speculated that there might be some more pathogenic mtDNA mutations that were unique to Chinese LHON patients.

In this study, we designed an AS-PCR to detect mutation m.10680G \> A in 774 Chinese patients with suspected LHON and found two patients harboring this mutation. Our approach had a reasonably good sensitivity in detecting minimum level of mutant DNA of 10% of total DNA template ≥ 10 ng). Compared to other approaches, such as sequencing, single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP), the AS-PCR method is fast and cost-effective and can be of potential usage in the clinic for fast screening of mutation m.10680G \> A in patients with suspected LHON. We did not identify any heteroplasmy of mutation m.10680G \> A in the two patients with m.10680G \> A in this study and patient Le1107 in our previous study \[[@B15]\] based on the limitation of detection sensitivity of our AS-PCR and direct sequencing approach. Though we did not design an allele-specific PCR (or a PCR-RFLP method) to detect the minimum level of wild-type allele in these patients to double check for heteroplasmy, the overall pattern was consistent with our previous observation for a very low frequency of heteroplasmic m.11778G \> A (1/479 = 0.21%; Ref. \[[@B17]\]) and m.14484T \> C (3/52 = 5.8%; Ref. \[[@B30]\]) in Han Chinese patients. As m.10680G \> A creates a digestion site for enzyme *Tse*I, we could also use PCR-RFLP method to screen this mutation and measure the level of heteroplasmy. One limitation is that enzyme *Tse*I is quite expensive and this PCR-RFLP method is not cost-effective and time-consuming in clinic.

The frequency of m.10680G \> A in Chinese LHON patients was slightly lower than that of primary mutation m.3635G \> A \[[@B7]\]. Although the conservation index (0.84) of p.A71T (m.10680G \> A) was not as high as one would expect for a pathogenic mutation, it would affect the secondary or tertiary structure of the ND4L subunit (Figure [4](#F4){ref-type="fig"}). The alanine to threonine change at the 71^st^amino acid position is next to E70, one of the two highly conserved glutamates in transmembrane helices of the ND4L protein, and those glutamates have been shown to be essential for enzyme activity \[[@B31]\]. Moreover, the two glutamates within transmembrane helices of nuoK/ND4L have been recently considered to be linked to the proton pumping function of complex I (NADH:ubiquinone oxidoreductase) in light of the recently revealed spatial structure of the membrane arm of complex I in *E. coli*\[[@B32],[@B33]\]. Therefore, there indeed seem to be reasons for the pathogenicity of mutation m.10680G \> A.

![**Membrane-spanning region prediction plot produced by the TMpred program**. This program (<http://www.ch.embnet.org/software/TMPRED_form.html>) makes a prediction of membrane-spanning regions and their orientation. Mutation p.A71T (m.10680G \> A) changed the structure of membrane-spanning region of the MT-ND4L protein.](1479-5876-10-43-4){#F4}

A web-based and database search showed that mutation m.10680G \> A has been independently reported to affect LHON in two Chinese families \[[@B15],[@B16]\]. These two reported patients belonged to haplogroups M13a \[[@B15]\] and B4d \[[@B16]\] (Figure [3](#F3){ref-type="fig"}). Therefore, it seemed that mutation m.10680G \> A occurred only in Chinese LHON patients and had a multiple occurrence in different mtDNA background. In the Chinese family reported by Yang *et al.*\[[@B16]\], m.10680G \> A coexisted with primary mutation m.14484T \> C, and the presence of both mutations caused complete penetrance of LHON. In the two families with m.10680G \> A reported in this study and our previous study \[[@B15]\], we found that the penetrance of LHON (\> 40%) was even higher than those families with m.11778G \> A (33.3%; Ref. \[[@B8]\]), m.14484T \> C (31.9%; Ref. \[[@B30]\]) or m.3460G \> A (25.6%; Ref. \[[@B29]\]). Patient Le1263 was self-reported as sporadic and his family was not considered to calculate the penetrance. Note that our estimation for disease penetrance for m.10680G \> A was based on two families, which might lead to a bias.

Analysis for the entire mtDNA genomes of the two patients with m.10680G \> A identified in this study showed that they harbored no novel or \"confirmed\" pathogenic mutation. However, variant m.3548T \> C was found in patient Le1263, which is located in the mutational hotspot (*MT-ND1*gene) for Chinese patients with LHON but lacking three known primary mutations \[[@B15]\] and was also reported in another LHON patient \[[@B25]\], whether m.3548T \> C had a synergistic effect with m.10680G \> A to influence disease expression in Le1263 was not clear, as we lacked necessary clinical information and this patient had no self-reported family history of disease. Similarly, two private variants were found in patient Le1330, which were located in the *MT-ND1*and *MT-ND5*genes (Table [1](#T1){ref-type="table"}), further supported our previous claim that the *MT-ND1*and *MT-ND5*genes are mutational hotspots for Chinese families with clinical features of LHON but lacking the three primary mutations \[[@B15]\].

Conclusion
==========

In summary, we designed an AS-PCR method for rapid screening of m.10680G \> A in a large cohort of Chinese patients with suspected LHON and identified two Chinese subjects with m.10680G \> A. Analysis of the complete mtDNA sequences of the two probands and combining with information of two reported cases \[[@B15],[@B16]\], we proposed that m.10680G \> A is a rare pathogenic mutation in Chinese LHON population. Further functional assays, e.g. respiration measurements and NADH:ubichinon oxidoreductase activity assays in patient fibroblasts and eventually in newly constructed cybrid cell lines harbouring the mutation, should be carried out and more families with m.10680G \> A should be included to validate our conclusion.
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